A murine model of FGFR2 fusion driven intrahepatic cholangiocarcinoma to delineate the mechanism of therapeutic response and resistance to FGFR inhibitors
Preview
Cite
Access Statistic

Rights
Use and reproduction:
All rights reserved
Use and reproduction:
All rights reserved